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Abstract
Background: Despite evidence suggesting a role in plant defence, the use of plant lectins in crop
protection has been hindered by their low and species-specific insecticidal activity. Snowdrop lectin
(Galanthus nivalis agglutinin; GNA) is transported to the haemolymph of insects after oral ingestion,
and can be used as a basis for novel insecticides. Recombinant proteins containing GNA expressed
as a fusion with a peptide or protein, normally only toxic when injected into the insect
haemolymph, have the potential to show oral toxicity as a result of GNA-mediated uptake.
Results:  A gene encoding a toxin, ButaIT, from the red scorpion (Mesobuthus tamulus) was
synthesised and assembled into expression constructs. One construct contained ButaIT alone,
whereas the other contained ButaIT fused N-terminally to a GNA polypeptide (ButaIT/GNA). Both
recombinant proteins were produced using the yeast Pichia pastoris as an expression host, and
purified. Recombinant ButaIT and ButaIT/GNA were acutely toxic when injected into larvae of
tomato moth (Lacanobia oleracea), causing slow paralysis, leading to mortality or decreased growth.
ButaIT/GNA was chronically toxic when fed to L. oleracea larvae, causing decreased survival and
weight gain under conditions where GNA alone was effectively non-toxic. Intact ButaIT/GNA was
detected in larval haemolymph from insects fed the fusion protein orally, demonstrating transport
of the linked polypeptide across the gut. Proteolysis of the fusion protein was also observed.
ButaIT/GNA was significantly more toxic that GNA alone when fed to the homopteran Nilaparvata
lugens (rice brown planthopper) in liquid artificial diet.
Conclusion: The ButaIT/GNA recombinant fusion protein is toxic to lepidopteran larvae both
when injected and when fed orally, showing the utility of GNA as a carrier to transport potentially
toxic peptides and proteins across the insect gut. Although ButaIT has been claimed to be
lepidopteran-specific, the fusion protein has more wide-ranging insecticidal activity. Fusion proteins
based on plant lectins have potential applications in crop protection, both as exogenously applied
treatments and as endogenous products in transgenic plants.
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Background
Scorpion venoms are a rich source of polypeptides with
diverse biological activities, including many neurotoxins
that exert their action via target-specific modulation of ion
channel function (reviewed in [1,2]). Among the well-
characterised peptide toxins are those derived from the
venom of scorpions belonging to the family Buthidae.
These toxins are classified into two groups, based on their
molecular size and activity. The first group contains short
toxins (30–40 amino acid residues), with 3–4 disulphide
bridges, which principally affect voltage-dependent potas-
sium channels and conductance calcium-activated potas-
sium channels [3,4]. The second group contains longer
toxins (60–70 amino acid residues), cross-linked by 4
disulphide bridges, which mainly effect voltage-depend-
ent sodium channels of excitable cells [5,6]. Despite the
similarity of invertebrate and vertebrate ion channels,
many scorpion neurotoxins exhibit specificity towards
particular species or groups of species. This specificity of
action gives scorpion toxins, and other proteins with sim-
ilar properties, significant potential in the development of
safer alternatives to broad spectrum insecticides. Recom-
binant baculovirus expressing scorpion toxins have been
proposed as insect control agents, and have given promis-
ing results in laboratory, glasshouse and field, although
this has not led to wide-scale adoption of the technology
(reviewed in [7]).
The isolation and characterization of a novel short, lepi-
dopteran-selective toxin (ButaIT; also referred to as
BtChl2; Swiss-Prot [P81761]) from the venom of the
South Indian red scorpion (Mesobuthus tamulus) was
reported by Wudayagiri et al. [8]. Injection of Heliothis
virescens with ButaITA (purified to homogeneity by hplc;
fraction CM-IV-6A) was shown to cause larval mortality
through progressive, irreversible, flaccid paralysis at a
dose of 1 µg/100 mg, but was non-toxic to blowfly larvae
at the same dose, or mice at a dose of 3 µg/g body weight.
The mature form of ButaIT is a single polypeptide of 37
amino acid residues, cross-linked by four disulfide
bridges, that exhibits high sequence similarity to other
short toxins. The sequence of a cDNA encoding a precur-
sor form of ButaIT (referred to as BtChl2) has been lodged
in the databases (Genbank [AF481881]); the precursor is
a polypeptide of 62 amino acids, which is modified by
removal of a 24-residue N-terminal signal peptide, and a
single residue from the C-terminus, to give the mature
protein.
Snowdrop lectin (GNA; Galanthus nivalis agglutinin) has
been shown to bind to the gut epithelium when fed to
insects, and can be detected in the circulatory system [9].
The use of GNA as a carrier to transport fused proteins to
the haemolymph of target species after oral ingestion has
been demonstrated, and can result in insecticidal effects
not shown by ingestion of either the lectin or the fused
protein separately. When a fusion protein containing
GNA and a C-terminally fused insect neuropeptide (Man-
duca sexta allatostatin) was fed to lepidopteran larvae,
reductions in survival, and in growth and feeding, were
observed [10] In addition, fusion protein could be
detected in the larval haemolymph by immunoassay.
Similarly, GNA has been used to deliver an N-terminally
fused insect-specific neurotoxin, Sfl1, derived from the
venom glands of the spider Segestria florentina, to the
blood of target species, causing insecticidal effects [11].
This paper reports on the production, purification and
biological activities of a recombinant fusion protein,
ButaIT/GNA, containing the ButaIT polypeptide fused to
the N-terminus of snowdrop lectin, as a means of deliver-
ing ButaIT to insects via oral ingestion. The ButaIT/GNA
fusion protein was toxic towards lepidopteran larvae both
when injected into the haemolymph, and when fed in
artifical diet. Direct evidence for the delivery of intact
ButaIT/GNA to the haemolymph of orally-fed insects is
presented. In contrast to the earlier results showing that
ButaIT was specifically toxic to lepidopteran insects, the
ButaIT/GNA fusion protein was found to be toxic towards
insects of different orders.
Results
Construction of a synthetic gene encoding the red scorpion 
neurotoxin ButaIT and assembly of expression constructs
A synthetic gene containing the entire coding sequence for
the mature ButaIT polypeptide (as given in Genbank
[AF481881]) was assembled from overlapping oligonu-
cleotides. Each of the two complementary strands of the
gene contained four 30-mers and one 15-mer, arranged so
that overlaps of 15 bases between complementary por-
tions of the oligos were present. The oligonucleotides
were phosphorylated prior to annealing, and the desired
product was amplified by PCR after annealing and ligat-
ing, using the 15-mer oligonucleotides at the 5' end of
each strand as primers. A DNA fragment corresponding to
the correct size for the complete product was obtained,
and was excised from gel, cloned in an intermediate vec-
tor, and verified by DNA sequencing. The resulting frag-
ment corresponded to the desired coding sequence, with
additional restriction sites introduced at the ends to allow
for subsequent cloning.
The ButaIT coding sequence was assembled into two con-
structs for expression of proteins in the yeast Pichia pastoris
using the shuttle expression vector pGAPZαB. The first
construct contained ButaIT alone, and the second
encoded a fusion protein in which ButaIT is fused to the
N-terminus of residues 1 – 105 of mature GNA via a 3
amino acid linker peptide (Fig. 1). Both constructs were
arranged so that the recombinant proteins were producedBMC Biotechnology 2006, 6:18 http://www.biomedcentral.com/1472-6750/6/18
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Assembly of the expression constructs for ButaIT and ButaIT/GNA Figure 1
Assembly of the expression constructs for ButaIT and ButaIT/GNA. The predicted sequences of the mature proteins 
produced by the P. pastoris expression system are shown.
AARCGPCFTTDPQTQAKCSECCGRKGGVCKGPQCICGIQYVDHHHHHH
AARCGPCFTTDPQTQAKCSECCGRKGGVCKGPQCICGIQAAA
DNILYSGETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSC
FLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWATG
FLEQKLISEEDLNSAVDHHHHHH
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Production of recombinant proteins Figure 2
Production of recombinant proteins. (A). Analysis of partially purified ButaIT by SDS-PAGE (Tris-Tricine buffer system); 
gel stained with Coomassie blue. Arrow indicates ButaIT polypeptide, based on reaction with anti-(his)6 antibodies on Western 
blot. (B), (C). Purification of ButaIT/GNA by gel filtration. Following partial purification by phenyl-Sepharose chromatography 
recombinant proteins were loaded onto a Sephacryl S200 column equilibrated in PBS buffer. (B) absorbance profile and (C) 
corresponding fractions run on SDS-PAGE (15 % acrylamide gel, stained with Coomassie blue). The arrow depicts purified 
ButaIT/GNA.
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as precursors containing the yeast α-factor prepro-
sequence at the N-terminus; this sequence directs the
product into the secretory pathway in the expression host,
and is removed during translation and subsequent trans-
port. The final protein product for ButaIT is predicted to
contain a 9 amino acid C-terminal extension, containing
the (his)6 tag, and is predicted to have 2 extra alanine res-
idues at the N-terminus after removal of the prepro-
sequence, The predicted protein product for ButaIT/GNA
contains a C-terminal extension of 23 amino acids,
including a myc epitope tag and the (his)6 tag (Fig. 1).
Constructs were assembled by restriction/ligation and
cloning in E. coli, and were verified by DNA sequencing.
Expression and purification of recombinant ButaIT and 
ButaIT/GNA
DNA from verified clones of the expression construct plas-
mids was linearised and transformed into competent cells
of a protease-deficient Pichia pastoris strain. Since the
expression vector contains a constitutive yeast promoter,
clones selected as positive for transformation by antibiotic
resistance and colony PCR were tested for expression of
recombinant proteins in small-scale cultures. Culture
supernatants were assayed for the presence of recom-
binant proteins by immuno-dot blot and Western blot-
ting, using antibodies to the C-terminal tags, or in the case
of the ButaIT/GNA fusion, to GNA. Clones expressing
recombinant proteins at higher levels (relative to other
clones) were selected for further study.
For production of recombinant proteins, selected yeast
clones expressing ButaIT and ButaIT/GNA were grown in
a bench-top fermenter. ButaIT and ButaIT/GNA were par-
tially purified from culture supernatant by hydrophobic
interaction chromatography on phenyl-Sepharose.
Recombinant ButaIT was produced in relatively low yield
(<1 mg/l culture). The partially purified material con-
tained a polypeptide of estimated mol. wt. approx. 10,000
as the major component (fig. 2A); when a gel separation
was analysed by Western blotting, and probing with with
anti-(his)6 antibodies, the band gave a strong and specific
reaction, showing that this band represents recombinant
ButaIT. The discrepancy in size between predicted and
estimated mol. wts. for this polypeptide is consistent with
previous results in which small toxin polypeptides with
high cysteine content show anomalous migration on SDS-
PAGE.
ButaIT/GNA was produced at a yield of 25–35 mg/l cul-
ture medium, and was the major protein component of
the material eluted from the hydrophobic interaction col-
umn by a water wash. Further purification of ButaIT/GNA
by gel filtration was carried out to remove contaminating
yeast proteins (fig. 2B). Analysis of purified ButaIT/GNA
by SDS-PAGE (Fig. 2C) shows one major component of
approx. 18.5 kDa, which is close to the predicted molecu-
lar weight of 19.4 kDa. A minor component (weakly
stained band) of approx. 17 kDa is also present. Both
bands were immunoreactive towards anti-GNA antibod-
ies (data not presented), but only the major component
reacted with anti-(his)6 antibodies. The indicated size of
these polypeptides, and their immunoreactivity, suggest
that the majority of ButaIT/GNA is full-length protein
with the C-terminal extension intact, with a small propor-
tion of ButaIT/GNA from which the C-terminal his tag has
been removed. Recombinant ButaIT/GNA agglutinated
rabbit erythrocytes at a comparable concentration to
native GNA (50 µg/ml for ButaIT/GNA, vs. approx. 10 µg/
ml for GNA), showing that the lectin part of the fusion
protein is functional.
While the ButaIT/GNA could be produced as intact fusion
protein, prolonged exposure to proteases, such as those in
yeast culture supernatant, resulted in varying amounts
(normally <50%, as estimated by band staining intensity)
of proteolytic cleavage. Proteolysis occurred predomi-
nantly at or near the linker region between ButaIT and
GNA, and generated a polypeptide, mol. wt. approx.
12,000, which reacted with anti-GNA and anti-(his)6 anti-
bodies. When band intensities were compared for the
same protein samples between stained gels and Western
blots, it was apparent that the anti-GNA antibody gave a
stronger reaction with the 12,000 mol. wt band than with
the intact fusion protein; as a consequence, the extent of
cleavage of the fusion is overestimated in Western blots.
Toxicity of recombinant proteins to tomato moth larvae 
after injection into the haemocoel
The toxicity of recombinant ButaIT was demonstrated by
injection into fifth stadium L. oleracea larvae (approx. 30
– 60 mg). Injection of the partially purified recombinant
protein at doses of the order of 1–10 µg caused a decline
in larval suvival over a period of 7 days, to less than 30%.
Control survival (buffer-injected, or injected with other
partially purified recombinant proteins) was >70% over 7
days. The effect was dose-dependent, and at high doses of
ButaIT 100% mortality was observed after 3 days, during
which time control survival was >90%. These results could
not be compared with previously published data for tox-
icity of the protein purified from scorpion venom, as the
recombinant protein could not be quantified, and
attempts to purify it further were not successful. However,
the data show that expression as a recombinant protein in
P. pastoris did not abolish the toxicity of ButaIT.
The ButaIT/GNA fusion protein was also toxic when
injected into 5th stadium  L. oleracea larvae. The major
effect on mortality was seen during the first two days after
injection, after which survival (particularly at higher
doses) stabilised. The effect was dose dependent; injectionBMC Biotechnology 2006, 6:18 http://www.biomedcentral.com/1472-6750/6/18
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of 20 µg of fusion protein per larva (approx. 500 µg per g
insect; n = 10) reduced survival to 40% after 6 days,
whereas injection of 4 µg of fusion per larva (approx. 100
µg per g insect; n = 25) reduced survival to 60%. Control
survival was 97% over this interval (n = 40). Injection of
GNA at 20 µg per larva (approx. 500 µg per g insect; n =
20) had no effect on survival, which was 95% over 6 days
(fig. 3); thus the toxic effect shown by ButaIT/GNA on
injection must be due to the toxin fused to GNA. Surviv-
ing insects that had been injected with ButaIT/GNA also
showed a reduction in weight gain compared to controls
(PBS-injected). The effect was variable, but in a represent-
ative assay injection of approx. 100 µg per g insect of the
Survival of L. oleracea larvae following injection of purified  recombinant proteins Figure 3
Survival of L. oleracea larvae following injection of 
purified recombinant proteins. Survival was recorded 
for fifth stadium L. oleracea larvae following injections of 
recombinant GNA or ButaIT/GNA. Control insects were 
injected with phosphate buffered saline (PBS; n = 40). GNA 
was injected at a dose of 20 µg which equates to approx. 500 
µg GNA/g insect (n = 20); ButaIT/GNA was injected at two 
different concentrations; 4 µg which equates to approx. 100 
µg fusion protein or 30 µg toxin/g insect (n = 25), and 20 µg 
which equates to approx. 450 µg of fusion protein or 135 µg 
toxin/g insect (n = 10).
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Survival and weight gain for L. oleracea larvae fed diets con- taining purified recombinant proteins Figure 4
Survival and weight gain for L. oleracea larvae fed 
diets containing purified recombinant proteins. (A). 
Survival of third stadium L. oleracea larvae fed for 12 days on 
control diet or diets containing recombinant ButaIT/GNA at 
4.5 % dietary protein. (B) Mean weight of third stadium L. 
oleracea larvae fed for 12 days on control diet or diets con-
taining recombinant ButaIT/GNA at 4.5 % and 2.5 % dietary 
protein, or recombinant GNA at 5 % dietary protein. Data 
has been combined for 2 assays carried out under the same 
conditions, and thus data for two control treatments is pro-
vided. n = 20 per treatment (control total n = 40). Points and 
bars denote mean ± SE.
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fusion protein reduced weight gain over 6 days by approx.
40% (starting weight 38 ± 2 mg, final weight for controls
205 ± 17 mg, for ButaIT/GNA injected insects 134 ± 19
mg, n = 20 for each treatment, significantly different at p
< 0.01). Injection of GNA at similar dose had no effect on
weight gain.
Toxicity of recombinant proteins to tomato moth larvae 
after oral delivery via artificial diet
Third stadium tomato moth larvae were exposed to diet
containing recombinant ButaIT/GNA at 2.5% and 4.5%
of dietary protein. Delivery of the toxin via this route had
little or no acute toxicity to larvae, but long-term effects on
larval survival and development were observed. As shown
in Fig 4A, survival of larvae fed on diet containing ButaIT/
GNA at 4.5% of total protein declined significantly after
day 8 of the assay, so that only 75% of larvae remained
alive after 12 days of feeding, compared to 100% of larvae
fed on control diet. Exposure to the lower dose of ButaIT/
GNA did not have a significant effect on survival over a
similar time period. Similarly, exposure to GNA in the diet
at 5% of total protein had no effect on survival over 12
days.
Surviving larvae fed on the ButaIT/GNA-containing diets
showed a significant reduction in mean larval weight
compared to the control diet treatment for all time points
after day 4 of the bioassay (ANOVA; p < 0.05), so that by
day 12 of the bioassay the mean weight of surviving
ButaIT/GNA-fed larvae (both doses) was approx. 40 %
less than that recorded for control insects (Fig. 4B). The
consumption of diet correlated with larval growth, so that
overall, ButaIT/GNA at 4.5 % of total protein caused a
reduction of approx. 35 % of total diet consumed, com-
pared to control treatment, and ButaIT/GNA at 2.5 % of
total protein caused a reduction of approx. 30% in diet
consumption. Feeding GNA at 5% of total protein in the
diet had only marginal, insignificant effects on growth
and consumption (Fig. 4B).
Presence of ButaIT/GNA in tomato moth larval tissues after oral 
administration
Gut tissue and haemolymph samples were extracted from
larvae exposed to ButaIT/GNA at 2.5 % of dietary protein
for 24 h and 8 days, and from larvae exposed ButaIT/GNA
at 4.5 % of dietary protein for 12 days. Typically samples
were pooled from 3 insects to give 2 – 4 replicates in each
instance. Western blot analysis, using anti-GNA antibod-
ies as a probe, was used to verify binding of the fusion pro-
tein to the guts of orally exposed larvae, and uptake of
ButaIT/GNA into the haemolymph. Fig. 5 represents a
summary of the results obtained. In all cases immunore-
activity of two major bands with anti-GNA antibodies was
observed in samples from insects fed ButaIT/GNA, but not
control insects. These bands, present in both gut and
haemolymph samples, correspond in molecular weight to
the sizes of ButaIT/GNA and GNA. The susceptibility of
fusion proteins based on GNA to proteolytic cleavage in
the region of the linker peptide between GNA and the
fused peptide/polypeptide has been observed previously
for other recombinant fusion proteins [11,12], and has
been noted above for ButaIT/GNA. When compared to
standards, the ButaIT/GNA fusion protein detected in
both gut and blood samples from ButaIT/GNA-fed larvae
showed a reduction in the intensity of the band corre-
sponding to intact fusion protein, and a concurrent
increase in the band corresponding to GNA. The results
implied that limited proteolysis of the ButaIT/GNA fusion
occurs during ingestion, passage through the gut, and
transport to the haemolymph. Analysis of gut contents
from ButaIT/GNA-fed insects by Western blotting sug-
gested that most of the proteolytic cleavage of the fusion
protein occurred during the digestive processes occurring
in the gut lumen (fig. 5). Analysis of proteins extracted
from artificial diet showed that the fusion protein was not
proteolytically cleaved as a result of incorporation into the
Presence of ButaIT/GNA fusion protein in gut and haemol- ymph of L. oleracea larvae following feeding Figure 5
Presence of ButaIT/GNA fusion protein in gut and 
haemolymph of L. oleracea larvae following feeding. 
Samples were taken from third stadium L. oleracea larvae fed 
for 12 days on control diet (C), or diet containing ButaIT/
GNA (F; 4.5 mg/5 g diet). Proteins were resolved by 15 % 
acrylamide SDS-PAGE gel, electroblotted onto nitrocellu-
lose, and probed with anti-GNA antibodies. Loading is as fol-
lows: lanes 1, 3, 5 and 11 are control diet, gut tissue, gut 
contents and haemolymph respectively; lanes 2, 4, 6, 7 and 12 
are ButaIT/GNA diet, gut, gut contents and haemolymph; 
lane 8 is a GNA standard (10 ng); lanes 9 & 10 are ButaIT/
GNA standards of 25 and 50 ng, respectively. Loading, as 
estimated by Bradford assay, was 40 µg total protein for all 
gut and haemolymph samples.
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diet, and that it remained intact over a period of 2–3 days
(Fig. 5).
Effects of ButaIT/GNA on non-lepidopteran insects
The toxicity of ButaIT/GNA towards non-lepidopteran
insects was tested using the homopteran species Nilapar-
vata lugens (rice brown planthopper). The fusion protein
was fed to insects by incorporation into liquid diet at a
concentration of 0.05% (0.5 mg/ml diet), and its effects
on survival were compared to GNA at a similar concentra-
tion. Results are shown in fig. 6. Control survival over the
8-day bioassay was approx. 40%, and at day 6, when all
insects on the "water only" control had died, was approx.
50%. Corrected mortality values, based on day 6 of the
assay, were 64 ± 11% for GNA and 92 ± 5% for ButaIT/
GNA; these are significantly different at p < 0.01 (survival
analysis). At all times after day 1 the effect of ButaIT on
survival was greater than that of GNA in these bioassays.
Western blotting analysis of samples of diet after N. lugens
feeding showed that ButaIT/GNA was stable in the diet
over a 2-day interval, with only a small amount of prote-
olysis of the fusion observed (data not presented).
Discussion
ButaIT belongs to the sequence family of "short" scorpion
toxins, which have a common pattern of cysteine residues
and are thought to share a common core structure, con-
taining one α-helix and three β-strands [8]. On the basis
that there is more sequence variability at the C-terminus
of these proteins than at the N-terminus, where a com-
pletely conserved cysteine residue is always amino acid
residue 2, the ButaIT/GNA fusion protein was designed
with the scorpion toxin N-terminal to the lectin, with the
expectation that this orientation would be more likely to
result in the fusion protein retaining toxicity. Previous
fusion proteins based on GNA have shown that the lectin
functionality is retained in both N- and C-terminal
fusions [10-12]. Expression of the toxin itself as a recom-
binant protein containing a C-terminal fusion "tag"
sequence would confirm that C-terminal extensions to
ButaIT did not abolish toxicity. The availability of a com-
plete cDNA sequence encoding a precursor of ButaIT
made assembling a synthetic coding sequence for the
mature protein a straightforward exercise.
The high level of cysteine in ButaIT, which is assumed to
contain 4 cys-cys cross-links in a 37-residue protein,
required that an expression system capable of correctly
forming cys-cys cross-links was used to express the recom-
binant protein. The use of Pichia pastoris as an expression
host has proved successful in our hands for expressing
other cysteine-rich cross-linked proteins, such as the spi-
der venom toxin SflI [11], in a soluble, functional form,
and is also able to produce functional, soluble plant
lectins [13]. P. pastoris was thus used as expression host for
both ButaIT and the ButaIT/GNA fusion, with both
recombinant proteins engineered for secretion into cul-
ture supernatant. Comparison of the toxicity of recom-
binant ButaIT with the material purified from scorpion
venom by HPLC [8] was not possible, since only partially
purified recombinant toxin was available. However, the
fusion protein was fully purified and the delivered dose
could be properly quantified. The ButaIT purified from
scorpion venom caused induction of progressive, irrevers-
ible paralysis in Heliothis virescens larvae 30 min – 24 h
after injection at a dose of 1 µg/100 mg insect; in compar-
ison, injection of ButaIT/GNA at 3 – 13 µg/100 mg insect
in L. oleracea larvae caused mortalities of 40–60%. These
data suggest that the toxicity of ButaIT in the fusion pro-
tein may be compromised to some extent, but is not abol-
ished, and the fusion protein is still an effective toxin.
Previous studies using recombinant fusion proteins com-
bining snowdrop lectin (GNA) linked either to the insect
Effects of purified recombinant proteins on survival of rice  brown planthopper Figure 6
Effects of purified recombinant proteins on survival 
of rice brown planthopper. Third instar juveniles of N. 
lugens were fed on water only (mortality control), liquid arti-
ficial diet (negative control) and diet containing recombinant 
proteins at 0.5 mg/ml (= 0.05% w/v). Graph shows mean sur-
vival per replicate of 10 insects (± SE, n = 10 for water, diet, 
ButaIT/GNA, n = 20 for GNA).
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neuropeptide (Manse-AS) or to an insect spider venom
neurotoxin (SFI1) have demonstrated that GNA can be
utilised as a transporter to deliver linked peptides to the
haemolymph of lepidopteran L. oleracea larvae [10,11].
The results presented in this paper provide further verifi-
cation of the use of GNA for the oral delivery of haemol-
ymph active toxins to the blood of insects. Evidence for
binding of the fusion protein to the gut and subsequent
delivery to the blood was provided by western analysis of
samples taken from fusion-fed larvae. GNA-immunoreac-
tive protein with a molecular weight consistent with the
recombinant ButaIT/GNA standard was seen to be present
in both gut and haemolymph samples from fusion-fed L.
oleracea larvae. A degree of proteolytic degradation of the
fusion was denoted by the increased intensity of an
immunoreactive band of the same size as GNA, concur-
rent with the decreased intensity of the band correspond-
ing to ButaIT/GNA. The degradation of ingested proteins
is part of the digestive process. Whilst GNA itself is resist-
ant to gut proteolysis, proteolytic cleavage of linker
regions, or polypeptides fused to GNA is to be expected
and has been observed previously [11,12]. Nevertheless,
sufficient biologically active ButaIT was delivered to the
blood to produce detrimental effects upon larvae exposed
to diet containing the fusion protein.
Previous studies with SflI/GNA, a fusion between a spider
neurotoxin (SflI) from S. florentina and GNA, also demon-
strated in vivo biological activity by injection of L. oleracea
larvae. SflI/GNA was seen to cause 40 % mortality 72
hours after injection of a dose of 18 – 25 µg/g insect [11].
This level of toxicity is slightly higher than the effects of
ButaIT/GNA on injection. SflI/GNA also showed higher
toxicity than ButaIT/GNA when fed to larvae in diet, with
20% mortality over a 4-day period and an almost com-
plete inhibition of growth when fed at levels comparable
to those for ButaIT/GNA. When SflI/GNA was fed at lower
levels, approx. 1% of total protein, it had no effect on sur-
vival, but caused a decrease in weight gain similar to that
observed for ButaIT/GNA at approximately 4.5% of total
protein. These results are most easily explained by a differ-
ence in sensitivity of L. oleracea larvae to the two toxins,
SflI and ButaIT, with SflI being more potent. In both cases
the analysis of haemolymph after feeding fusion protein
showed that intact fusion protein was present as a result
of GNA-mediated transport across the gut epithelium, and
thus oral toxicity would depend on the relative activity of
the toxin parts of the two fusion proteins. GNA itself has
no acute toxic effects in short-term feeding assays on well-
developed larvae.
The bioassays in which ButaIT/GNA was fed to N. lugens
show unambiguously that the fusion protein is more toxic
to these insects than GNA alone. The recombinant protein
used for these assays shows a similar level of toxicity to
previous assays using GNA purified from Galanthus nivalis
bulbs [14]. The characterisation of ButaIT previously
reported [8] suggested that this toxin is lepidopteran-spe-
cific, on the basis of non-toxicity to blowfly larvae. The
present results suggest that the specificity of ButaIT may be
broader, but could also be interpreted as an effect result-
ing from the fusion of the toxin to GNA. Injection assays
carried out with a range of insects have shown that the
ButaIT/GNA fusion protein is toxic to other non-lepidop-
teran insects (data not presented), and further work will
be required to define the range of pest species for which
this fusion protein may be an effective insecticide.
Conclusion
The ability of snowdrop lectin (GNA) to act as a carrier
protein to direct the transport of attached molecules into
the insect haemolymph has been demonstrated by the
production of a recombinant protein containing the lepi-
dopteran-specific toxin from the South Indian red scor-
pion (Mesobuthus tamulus) (ButaIT) fused N-terminally to
snowdrop lectin. The fusion protein (ButaIT/GNA) was
purified to more than 90 % homogeneity by hydrophobic
interaction chromatography and gel filtration chromatog-
raphy. Biological activity was confirmed by mortality of
larvae of tomato moth (Lacanobia oleracea) injected with
ButaIT/GNA, as compared to controls injected with buffer
or GNA (negative controls) or recombinant ButaIT (posi-
tive control). The fusion protein showed insecticidal activ-
ity when delivered orally to L. oleracea larvae; dietary
ButaIT/GNA caused a reduction in survival (at higher
dose) and a significant reduction in larval growth and
consumption, as compared to controls. Intact ButaIT/
GNA was present in the haemolymph of insects fed on
diet containing the fusion protein, showing that transport
from the gut had occurred. The ButaIT/GNA fusion pro-
tein was also significantly more toxic than GNA alone
when fed to the homopteran plant pest Nilaparvata lugens
(rice brown planthopper), suggesting that the ButaIT
toxin may have a broader insecticidal specificity than ini-
tially thought. Fusion proteins of this type have potential
applications in agriculture, both as insecticide sprays that
can be applied exogenously to crops, and as gene products
that can be synthesised endogenously by transgenic
plants.
Methods
Insects
Lacanobia oleracea were reared continuously on artificial
diet (Bown et al., 1997) at 25°C under a 16 h:8 h
light:dark regime. Nilaparvata lugens were kept on 20 day
old rice plants (Oryza sativa variety 'TN1'), at 28°C, 90%
RH, under a 16 h:8 h light:dark regime.BMC Biotechnology 2006, 6:18 http://www.biomedcentral.com/1472-6750/6/18
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Materials and recombinant DNA techniques
A cDNA containing the GNA coding sequence has been
described previously [15]. Sub-cloning was carried out
using the TOPO cloning kit (pCR2.1 TOPO vector) pur-
chased from Invitrogen [16]. P. pastoris X33 strain and
SMD1168H (Protease A deficient) strain, the expression
vector pGAPZαB, and Easycomp Pichia transformation kit
were also from Invitrogen. Oligonucleotide primers were
synthesised by Sigma-Genosys Ltd. [17]. Restriction endo-
nucleases, T4 polynucleotide kinase, T4 DNA ligase, and
Pfu  DNA polymerase, were supplied by Promega [18].
Plasmid DNA was prepared using Promega Wizard mini-
prep kits. GNA was obtained from Vector Laboratories
Inc. or was produced as a recombinant protein in yeast
[13]. Anti-GNA antibodies, raised in rabbits, were pre-
pared by Genosys Biotechnologies, Cambridge, UK, and
anti-(His)6 (C-terminal) antibodies were from Invitrogen.
General molecular biology protocols were as described by
Sambrook and Russell [19] except where otherwise noted.
All DNA sequencing was carried out using dideoxynucle-
otide chain termination protocols on Applied Biosystems
automated DNA sequencers by the DNA Sequencing Serv-
ice, School of Biological and Biomedical Sciences, Univer-
sity of Durham, UK. Sequences were checked and
assembled using Sequencher software [20] running on
Mac OS computers.
Assembly of expression constructs for recombinant 
proteins
The ButaIT amino acid sequence (Genbank [AF481881])
was used as the basis for the assembly of a synthetic
ButaIT gene. Each strand (i.e. coding and complementary
strands) of the sequence encoding the mature ButaIT
chain (114 nucleotides) was subdivided into 5 fragments,
in such a way that each fragment overlapped neighbour-
ing fragments on the complementary strand by 10–15
bases. Ten oligonucleotide primers based on these frag-
ments were synthesised, and used in an assembly reaction
of the full mature ButaIT coding sequence.
The oligonucleotides used were as follows:
Coding strand:
5'-TCGCCTGCAGCAAGGT-3'
5'-GTGGTCCTTGCTTTACAACTGATCCTCAAA-3'
5'-CACAAGCCAAGTGTAGTGAGTGTTGTGGGC-3'
5'-GAAAGGGTGGAGTATGCAAGGGCCCACAAT-3'
5'-GTATCTGTGGTATACAATACGTCGACCGGCAA-3'
Complementary strand:
5'-TTGCCGGTCGACGTATT-3'
5'-GTATACCACAGATACATTGTGGGCCCTTGC-3'
5'-ATACTCCACCCTTTCGCCCACAACACTCAC-3'
5'-TACACTTGGCTTGTGTTTGAGGATCAGTTG-3'
5'-TAAAGCAAGGACCACACCTTGCTGCAGGCGA-3"
The primers at the 5' and 3' ends of the coding sequence
contained Pst I, and Sal I restriction sites (underlined),
respectively, which were used to allow subsequent cloning
of the ButaIT gene into the expression vector pGAPZαB.
All primers were individually 5'-phosphorylated using
enzyme T4 polynucleotide kinase. An equimolar solution
of phosphorylated primers in standard T4-DNA ligase
buffer (without adenosine triphosphate; ATP or dithioth-
reitol; DTT), was prepared in a final volume of 20 µl. The
mix was boiled for 10 min, to denature secondary struc-
tures, and slowly cooled to room temperature to allow
primers to anneal. After addition of ATP, DTT and DNA
ligase, a ligation reaction was carried out for 24 h at 16°C.
A PCR reaction was then performed, using sense and anti-
sense primers at the 5' and 3' ends of the ButaIT gene, to
obtain sufficient DNA for cloning into the intermediate
vector PCR 2.1. The resulting clones were verified by
sequencing. Subsequently, the ButaIT coding sequence
was excised as a Pst I/Sal I fragment from PCR2.1, and
cloned into the expression vector pGAPZαB to create
ButaIT- pGAPZαB.
To create a construct encoding the ButaIT/GNA fusion
protein, the sequence encoding the mature GNA peptide
(105 residues), derived from LECGNA2 cDNA [15] (Gen-
bank [A18023]), was excised from a previously generated
construct (SFI1/GNA-pGAPZαA, [11]) by restriction
digestion (5' Not I/3' Xba I) and ligated into ButaIT-pGAP-
ZαB, which had been digested with the same enzymes.
The expressed protein derived from this construct is
described in fig. 1.
The construct for expressing recombinant GNA as a con-
trol also contained amino acids 1–105 of the mature GNA
polypeptide (previously shown to produce a fully active
lectin) inserted as an EcoR I – Xba I fragment in the vector
pGAPZαA; the expressed protein, after post-translational
cleavage of the vector-encoded α-factor prepro-sequence
was predicted to contain two extra residues at the N-termi-
nus (EF...) and one at the C-terminus (...D); these extra
residues have been shown not to affect activity.BMC Biotechnology 2006, 6:18 http://www.biomedcentral.com/1472-6750/6/18
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Expression and purification of ButaIT and ButaIT/GNA
Constructs for expressing recombinant proteins were
transformed into P. pastoris (SMD1168H strain; ButaIT
and ButaIT/GNA or X33 strain; GNA) according to the
protocols supplied by Invitrogen [16]. Transformants
were selected by plating on media containing zeocin (100
µg/ml). Selected colonies were picked off and confirmed
as positive transformants by colony PCR using gene-spe-
cific primers. Clones expressing recombinant proteins
were identified by immuno-dot blot or Western analysis
of supernatants from small-scale cultures, using an anti-
(His)6 antibody (Invitrogen) for ButaIT, and anti-GNA
antibodies for ButaIT/GNA.
For protein production, P. pastoris cells containing the
ButaIT, ButaIT/GNA or GNA constructs were grown in
shake flasks (30°C with shaking), or a BioFlo 110 labora-
tory fermenter [21] as previously described [11], except
that the pH of the growing culture was maintained at 4.0.
Recombinant protein samples were purified using hydro-
phobic interaction chromatography on a phenyl-Sepha-
rose (Amersham-Pharmacia) column, as previously
described [11]. Recombinant ButaIT, ButaIT/GNA and
GNA eluted at low salt concentration, or in water, and
were analysed for purity by SDS-PAGE. Lyophilised
ButaIT/GNA and GNA were further purified using gel fil-
tration on a Sephacryl S-200 column (1.6 cm diameter, 90
cm length, 0.3 ml/min), equilibrated in PBS buffer. Frac-
tions containing purified ButaIT/GNA or GNA were
pooled, analysed for purity and concentration (absorb-
ance 280 nm; SDS-PAGE), prior to use in injection and
diet bioassays. Purified proteins were de-salted by dialysis
and freeze-dried, or de-salted and concentrated using
Microsep TM centrifugal concentrators (VivaScience AG,
Hannover, Germany).
Proteins were analysed routinely by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE). Samples were prepared
by adding 4× SDS sample buffer (containing 10% 2-mer-
captoethanol) and boiled for 5–10 min prior to loading.
For separation of low molecular weight polypeptides,
SDS-PAGE was carried out using a Tris-Tricine buffer sys-
tem according to the protocol of Schagger and von Jagow
[22]. Gels were either stained with Coomassie Blue, or
transferred to nitrocellulose using a Biorad Trans-blot SD
semi-dry transfer cell, according to the manufacturers rec-
ommendations.
Concentrations of purified recombinant proteins were
estimated by comparison with known amounts of stand-
ard GNA after SDS-PAGE, or Western blotting using anti-
GNA antibodies (1:3300 dilution) as previously described
in detail [23]. Haemagglutination assays were carried out
as described previously [13].
Insect Bioassays
Partially purified ButaIT and purified ButaIT/GNA and
GNA were tested for biological activity by injecting 5–10
µl of aqueous samples (freeze-dried protein re-suspended
in water or PBS) into fifth stadium L. oleracea larvae of
approx. 50–70 mg in weight. For each concentration
tested 10–15 larvae were injected and toxic effects moni-
tored over the next 7 days. PBS or water were injected as
negative controls; no difference was observed between
these two treatments, and survival over 2–3 days after the
injection was routinely >90%.
A potato leaf-based artificial diet [24] was used in assays
of the toxicity of recombinant ButaIT/GNA on oral deliv-
ery to lepidopteran larvae. For each treatment 20 newly
moulted third stadium L. oleracea larvae were maintained
in clear plastic pots containing moist filter paper to pre-
vent diet desiccation. Survival was monitored daily. Total
larval weights (± 0.1 mg) per treatment were recorded
daily for the first 4 days of the assay and subsequently,
individual larval wet weights (± 0.1 mg) were recorded
daily, and diet consumption (per replicate) was estimated
on a wet weight basis. The amount of recombinant
ButaIT/GNA and GNA added to diets was estimated as
described in section 2.4; control diets contained no added
protein.
Toxicity of proteins when fed to rice brown planthopper
was assayed using a liquid diet. An artificial diet (MMD-
1), suitable for the short-term maintenance of N. lugens,
was prepared according to Mitsuhashi [25]. Assays were
set up by placing five second instar N. lugens nymphs in
each feeding chamber, consisting of the base of a 35 mm
petri dish lined with moist filter paper. Two layers of Para-
film M® were stretched over the top, with 100 µl of artifi-
cial diet sandwiched between the two layers [26]. Feeding
chambers were kept at 28°C, 90 % RH, 16 h:8 h light:dark
regime, and the diet sachets were replaced every 2 days to
avoid contamination. A total of 10 replicates (50 insects)
were used per treatment, and survival was recorded daily
over 8 days. The amounts of recombinant ButaIT/GNA
and GNA added to diets was estimated as described in sec-
tion 2.4; diet containing no added protein was used as
negative control, and feeding chambers in which no diet
was available, but insects were kept moist ("water only")
were used as a positive control.
Analysis of haemolymph and gut tissue in L. oleracea 
larvae exposed to recombinant proteins
Haemolymph samples were extracted from L. oleracea lar-
vae injected with recombinant proteins, or exposed to
artificial diet containing ButaIT/GNA or GNA, as previ-
ously described [10]. Protein concentrations were esti-
mated by a microtitre-based Bradford assay (Biorad) using
BSA as the standard protein. Aliquots of haemolymphBMC Biotechnology 2006, 6:18 http://www.biomedcentral.com/1472-6750/6/18
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were analysed for the presence of GNA immunoreactivity
by Western blotting as described previously. Crude gut
extracts were also prepared from larvae exposed to ButaIT/
GNA diets to verify binding of the fusion protein to the
gut epithelium. Whole guts, dissected over ice, were
flushed with PBS to remove contents. Following homoge-
nisation, samples were centrifuged (12 000 × rpm, 4°C
for 20 mins) and the supernatant assayed for protein con-
centration prior to analysis by Western blotting. Diet sam-
ples were also prepared (as described for gut samples) for
analysis by Western blotting to confirm that fusion pro-
tein incorporated into artificial diet remained intact in 2–
3 day old diet.
Statistical analyses
All data analysis was carried out using the Statview (v. 5.0;
SAS Inc., Carey, NC, USA) software packages on Apple
Macintosh computers. Unpaired t-tests, ANOVA analysis
(Bonferroni-Dunn), Mann-Whitney non-parametric tests
and survival analyses were carried out to determine any
significant differences between treatments in the parame-
ters measured.
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